DAILY UPDATE
August 31, 2020
Dear Valued Reader,

I've gotten a few questions about the latest overhyped Paul Mampilly "Super Bull" pitch for Extreme Fortunes, so that's our target for the Thinkolator today -- the spiel promises the potentialf or 1,460% returns from a company that is a disruptor, has big growth ahead, and has some sort of unique technology that's key for the semiconductor industry... so what's the story, and is it worth any of my money?  Just click below to...


Most options traders place high-risk trades, hoping for a big payout. But they lose... a LOT! Especially in today’s topsy-turvy market. That's why Jim Fink flips options trading on its head, making money more than 85% of the time. Now, he's offering to show his personal strategy guide to readers which could help you unlock as much as $67,548 in extra income.

Get your copy by clicking here now.


Advertisement

Miss anything in the world of Gumshoe last week? 

The most popular article was also the first one, on Monday -- that was when I dug in to find some answers to Dan Ferris' tease about a “low risk” company that's a play on the “best business on earth”... with potential returns of 1,550%.  That sounds a bit optimistic, but there is something to the company... my story is here.

Then we were teased with something sexier -- Enrique Abeyta is pitching a tech stock that "builds the eyes" for self-driving vehicles, and he says it went public, quietly, and has the potential for 1,000% gains if you buy in before everyone knows about it.  Thinkolator answers are a click away.

After that I took a quick look at a stock that our longtime readers will be very familiar with -- Nick Hodge is teasing that one of the guys who profitted from "the big short" back in 2008 is betting even bigger on "the big long" now, in the form of a huge investment in a gold mining project that he says could be the biggest in America... our story is here.

Then it was another Stansberry pitch that drove questions our way, about Dave Lashmet's 20X opportunity on a weight loss drug... curious about that one?  Thinkolator results are right here.

And as usual, Friday brought the Friday File for my favorite people, the paid-up Irregulars who keep Stock Gumshoe going.   This week it's a hodgepodge of thoughts about several companies I've been buying of late, some quarterly updates, and a few long-winded responses to reader questions... just click below for that one...



Stock Gumshoe | travis@stockgumshoe.com | www.stockgumshoe.com
351 Pleasant St., Suite B #205, Northampton, MA 01060
Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

Having trouble viewing this email? Read the web version.

You may unsubscribe if you no longer wish to receive our emails. We have no wish to email people who don't want to receive these messages. Please note that unsubscribing applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.